Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: CT45A3 (cancer/testis antigen family 45 member A3) Homo sapiens
Analyze
Symbol: CT45A3
Name: cancer/testis antigen family 45 member A3
Description: Predicted to be involved in snRNA 3'-end processing. Predicted to localize to the integrator complex; INTERACTS WITH cadmium atom; copper atom; copper(0).
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: cancer/testis antigen 45-3; cancer/testis antigen 45-4; cancer/testis antigen 45A3; cancer/testis antigen 45A4; cancer/testis antigen CT45-3; cancer/testis antigen family 45 member A4; cancer/testis antigen family 45, member A3; cancer/testis antigen family 45, member A4; CT45-3; CT45-4; CT45.3; CT45.4; CT45A4; RP13-36C9.1; RP13-36C9.3
Orthologs:
No known orthologs. homologs ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38 EnsemblX135,759,846 - 135,768,191 (-)Ensembl
GRCh38X135,760,044 - 135,768,191 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh37X134,874,147 - 134,891,521 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36X134,711,154 - 134,719,185 (+)NCBINCBI36hg18NCBI36
CeleraX135,232,179 - 135,241,955 (+)NCBI
Cytogenetic MapXq26.3NCBI
CHM1_1X134,794,378 - 134,802,498 (+)NCBICHM1_1
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Position Markers
miRNA Target Status

Expression

RNA-SEQ Expression

Sequence

Nucleotide Sequences
Protein Sequences
Clinical Variants

Additional Information

External Database Links
Nomenclature History
 
More on CT45A3
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: hg19 hg38
HGNC Report
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1604675
Created: 2007-04-28
Species: Homo sapiens
Last Modified: 2019-12-25
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.